|
Volumn 66, Issue 1, 2007, Pages 149-150
|
Unusual late development of dopamine agonist resistance in two women with hyperprolactinaemia associated with transition from micro to macroadenoma [2]
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BROMOCRIPTINE;
CABERGOLINE;
DOPAMINE RECEPTOR STIMULATING AGENT;
PROLACTIN;
ADULT;
ANAMNESIS;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CASE REPORT;
CLINICAL ASSESSMENT;
CLINICAL FEATURE;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE ASSOCIATION;
DRUG DOSE ESCALATION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FEMALE;
GALACTORRHEA;
HUMAN;
HYPERPROLACTINEMIA;
HYPOPHYSIS TUMOR;
IMMUNOHISTOCHEMISTRY;
LETTER;
NAUSEA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
PROLACTINOMA;
REPEATED DRUG DOSE;
RETREATMENT;
SECONDARY AMENORRHEA;
TREATMENT FAILURE;
TREATMENT OUTCOME;
ADULT;
DISEASE PROGRESSION;
DOPAMINE AGONISTS;
DRUG RESISTANCE, NEOPLASM;
ERGOLINES;
FEMALE;
HUMANS;
HYPERPROLACTINEMIA;
MIDDLE AGED;
PITUITARY NEOPLASMS;
PROLACTINOMA;
|
EID: 33845679971
PISSN: 03000664
EISSN: 13652265
Source Type: Journal
DOI: 10.1111/j.1365-2265.2006.02686.x Document Type: Letter |
Times cited : (11)
|
References (5)
|